_id
69131429ccc777a4e85d7fe1
Ticker
MDCLF
Name
MedinCell S.A
Exchange
PINK
Address
3 Rue des Frères Lumière, Jacou, France, 34830
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.medincell.com
Description
MedinCell S.A., a clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France. The company develops solutions based on BEPO, a long-acting injectable technology. It offers UZEDY (mdc-IRM) for the treatment of schizophrenia in adults and bipolar I disorder. It is also developing mdc-TJK, a subcutaneous injection that is in the NDA preparation stage for the treatment of schizophrenia in adults; and mdc-CWM, a sustained-release formulation of celecoxib in Phase III trials for use in the treatment of reduction of postoperative pain and inflammation in total knee arthroplasty surgery. In addition, its product candidates in preclinical trials include mdc-WWM for contraception; and mdc-STM for malaria. It has strategic collaborations with AbbVie to develop, manufacture, and commercialize six long-acting injectable therapeutic products; and IM4TB to develop a long-acting injectable version of Macozinone for the treatment of tuberculosis. MedinCell S.A. was incorporated in 2003 and is based in Jacou, France.
Last Close
6.976
Volume
-
Current Price
6.976
Change
0
Last Updated
2026-01-05T10:16:13.213Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
232620176
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.5883333333333334
Sentiment Sources
3
Current Quarter
2025-09-30
Revenue
13621291
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
23247019
Operating Income
-10735802
Interest Expense
3334916
Pretax Income
-21808382
Net Income
-18866568
Eps
-0.5702647244154607
Dividends Per Share
-
Shares Outstanding
33345782
Income Tax Expense
-2941814
EBITDA
-17363391
Operating Margin
-78.81633246070436
Total Other Income Expense Net
-11072579
Cash
22849223
Short Term Investments
39932163
Receivables
8055665
Inventories
-
Total Current Assets
71997584
Property Plant Equipment
5681796
Total Assets
87511634
Payables
4295963
Short Term Debt
6598253
Long Term Debt
-
Total Liabilities
123456448
Equity
-35944814
Bs_currency_symbol
-
Depreciation
1110074
Change In Working Capital
-11232167
Cash From Operations
-16725040
Capital Expenditures
269891
Cash From Investing
8870032
Cash From Financing
-3027475
Net Change In Cash
3270984
Cf_currency_symbol
-
PE
-
PB
-6.420762838055024
ROE
52.487593898802764
ROA
-21.55892552526216
FCF
-16994931
Fcf Percent
-1.2476740273737636
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
0.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
2
Net Net Investing Score
0.5
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
13621291
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
23247019
Quarters > 0 > income Statement > operating Income
-10735802
Quarters > 0 > income Statement > interest Expense
3334916
Quarters > 0 > income Statement > pretax Income
-21808382
Quarters > 0 > income Statement > net Income
-18866568
Quarters > 0 > income Statement > eps
-0.5702647244154607
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
33083877
Quarters > 0 > income Statement > income Tax Expense
-2941814
Quarters > 0 > income Statement > EBITDA
-17363391
Quarters > 0 > income Statement > operating Margin
-78.81633246070436
Quarters > 0 > income Statement > total Other Income Expense Net
-11072579
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
22849223
Quarters > 0 > balance Sheet > short Term Investments
39932163
Quarters > 0 > balance Sheet > receivables
8055665
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
71997584
Quarters > 0 > balance Sheet > property Plant Equipment
5681796
Quarters > 0 > balance Sheet > total Assets
87511634
Quarters > 0 > balance Sheet > payables
4295963
Quarters > 0 > balance Sheet > short Term Debt
6598253
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
123456448
Quarters > 0 > balance Sheet > equity
-35944814
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-18866568
Quarters > 0 > cash Flow > depreciation
1110074
Quarters > 0 > cash Flow > change In Working Capital
-11232167
Quarters > 0 > cash Flow > cash From Operations
-16725040
Quarters > 0 > cash Flow > capital Expenditures
269891
Quarters > 0 > cash Flow > cash From Investing
8870032
Quarters > 0 > cash Flow > cash From Financing
-3027475
Quarters > 0 > cash Flow > net Change In Cash
3270984
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.5702647244154607
Quarters > 0 > ratios > PB
-6.420762838055024
Quarters > 0 > ratios > ROE
52.487593898802764
Quarters > 0 > ratios > ROA
-21.55892552526216
Quarters > 0 > ratios > FCF
-16994931
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-1.2476740273737636
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
16106000
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
16106000
Quarters > 1 > income Statement > operating Expenses
19417000
Quarters > 1 > income Statement > operating Income
-3311000
Quarters > 1 > income Statement > interest Expense
2777108
Quarters > 1 > income Statement > pretax Income
-3839000
Quarters > 1 > income Statement > net Income
-3870000
Quarters > 1 > income Statement > eps
-0.12156505299372476
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
31834807
Quarters > 1 > income Statement > income Tax Expense
31000
Quarters > 1 > income Statement > EBITDA
-3941000
Quarters > 1 > income Statement > operating Margin
-20.557556190239662
Quarters > 1 > income Statement > total Other Income Expense Net
-528000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
59040000
Quarters > 1 > balance Sheet > short Term Investments
12857000
Quarters > 1 > balance Sheet > receivables
3205000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
80617000
Quarters > 1 > balance Sheet > property Plant Equipment
5274000
Quarters > 1 > balance Sheet > total Assets
90452000
Quarters > 1 > balance Sheet > payables
3997000
Quarters > 1 > balance Sheet > short Term Debt
7294000
Quarters > 1 > balance Sheet > long Term Debt
49415000
Quarters > 1 > balance Sheet > total Liabilities
106819000
Quarters > 1 > balance Sheet > equity
-16367000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-3870000
Quarters > 1 > cash Flow > depreciation
1150000
Quarters > 1 > cash Flow > change In Working Capital
-2931813
Quarters > 1 > cash Flow > cash From Operations
-3077863
Quarters > 1 > cash Flow > capital Expenditures
597181
Quarters > 1 > cash Flow > cash From Investing
-7436636
Quarters > 1 > cash Flow > cash From Financing
40169090
Quarters > 1 > cash Flow > net Change In Cash
2384962
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.12156505299372476
Quarters > 1 > ratios > PB
-13.568742813710514
Quarters > 1 > ratios > ROE
23.645139610191237
Quarters > 1 > ratios > ROA
-4.278512360146818
Quarters > 1 > ratios > FCF
-3675044
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.22817856699366695
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2024-09-30
Quarters > 2 > income Statement > revenue
9435000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
9435000
Quarters > 2 > income Statement > operating Expenses
16964000
Quarters > 2 > income Statement > operating Income
-7529000
Quarters > 2 > income Statement > interest Expense
1774000
Quarters > 2 > income Statement > pretax Income
-14439000
Quarters > 2 > income Statement > net Income
-14568000
Quarters > 2 > income Statement > eps
-0.5006009238506204
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
29101025
Quarters > 2 > income Statement > income Tax Expense
129000
Quarters > 2 > income Statement > EBITDA
-7259000
Quarters > 2 > income Statement > operating Margin
-79.79862215156332
Quarters > 2 > income Statement > total Other Income Expense Net
-6910000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
31636000
Quarters > 2 > balance Sheet > short Term Investments
7217000
Quarters > 2 > balance Sheet > receivables
2877000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
47752000
Quarters > 2 > balance Sheet > property Plant Equipment
5176000
Quarters > 2 > balance Sheet > total Assets
58863000
Quarters > 2 > balance Sheet > payables
2365000
Quarters > 2 > balance Sheet > short Term Debt
7544000
Quarters > 2 > balance Sheet > long Term Debt
49878000
Quarters > 2 > balance Sheet > total Liabilities
112893000
Quarters > 2 > balance Sheet > equity
-54030000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
-14568000
Quarters > 2 > cash Flow > depreciation
840000
Quarters > 2 > cash Flow > change In Working Capital
26729000
Quarters > 2 > cash Flow > cash From Operations
21559000
Quarters > 2 > cash Flow > capital Expenditures
195000
Quarters > 2 > cash Flow > cash From Investing
-6993000
Quarters > 2 > cash Flow > cash From Financing
-2398000
Quarters > 2 > cash Flow > net Change In Cash
31636000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.5006009238506204
Quarters > 2 > ratios > PB
-3.757333895983713
Quarters > 2 > ratios > ROE
26.962798445308163
Quarters > 2 > ratios > ROA
-24.748993425411552
Quarters > 2 > ratios > FCF
21364000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
2.2643349231584526
Quarters > 2 > health Score
50
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
3765000
Quarters > 3 > income Statement > cost Of Revenue
329000
Quarters > 3 > income Statement > gross Profit
3436000
Quarters > 3 > income Statement > operating Expenses
15761000
Quarters > 3 > income Statement > operating Income
-11996000
Quarters > 3 > income Statement > interest Expense
4438000
Quarters > 3 > income Statement > pretax Income
-16792000
Quarters > 3 > income Statement > net Income
-16880000
Quarters > 3 > income Statement > eps
-0.5825943249721499
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
28973849
Quarters > 3 > income Statement > income Tax Expense
88000
Quarters > 3 > income Statement > EBITDA
-11551000
Quarters > 3 > income Statement > operating Margin
-318.6188579017264
Quarters > 3 > income Statement > total Other Income Expense Net
-4796000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
19460000
Quarters > 3 > balance Sheet > short Term Investments
-729000
Quarters > 3 > balance Sheet > receivables
2273000
Quarters > 3 > balance Sheet > inventories
829000
Quarters > 3 > balance Sheet > total Current Assets
27258000
Quarters > 3 > balance Sheet > property Plant Equipment
5434000
Quarters > 3 > balance Sheet > total Assets
36948000
Quarters > 3 > balance Sheet > payables
1849000
Quarters > 3 > balance Sheet > short Term Debt
6161000
Quarters > 3 > balance Sheet > long Term Debt
50541000
Quarters > 3 > balance Sheet > total Liabilities
77772000
Quarters > 3 > balance Sheet > equity
-40824000
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
-16880000
Quarters > 3 > cash Flow > depreciation
855000
Quarters > 3 > cash Flow > change In Working Capital
9233000
Quarters > 3 > cash Flow > cash From Operations
-163000
Quarters > 3 > cash Flow > capital Expenditures
172000
Quarters > 3 > cash Flow > cash From Investing
-423000
Quarters > 3 > cash Flow > cash From Financing
-6732000
Quarters > 3 > cash Flow > net Change In Cash
2634000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.5825943249721499
Quarters > 3 > ratios > PB
-4.951047683323535
Quarters > 3 > ratios > ROE
41.34822653341172
Quarters > 3 > ratios > ROA
-45.685828732272384
Quarters > 3 > ratios > FCF
-335000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.08897742363877822
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2025-03-31
Annuals > 0 > income Statement > revenue
25541000
Annuals > 0 > income Statement > cost Of Revenue
0
Annuals > 0 > income Statement > gross Profit
25541000
Annuals > 0 > income Statement > operating Expenses
36381000
Annuals > 0 > income Statement > operating Income
-10840000
Annuals > 0 > income Statement > interest Expense
5088000
Annuals > 0 > income Statement > pretax Income
-18278000
Annuals > 0 > income Statement > net Income
-18438000
Annuals > 0 > income Statement > eps
-0.6335859303924862
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
29101025
Annuals > 0 > income Statement > income Tax Expense
160000
Annuals > 0 > income Statement > EBITDA
-11200000
Annuals > 0 > income Statement > operating Margin
-42.44156454328335
Annuals > 0 > income Statement > total Other Income Expense Net
-7438000
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
59040000
Annuals > 0 > balance Sheet > short Term Investments
12857000
Annuals > 0 > balance Sheet > receivables
3205000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
80617000
Annuals > 0 > balance Sheet > property Plant Equipment
5274000
Annuals > 0 > balance Sheet > total Assets
90452000
Annuals > 0 > balance Sheet > payables
3997000
Annuals > 0 > balance Sheet > short Term Debt
7294000
Annuals > 0 > balance Sheet > long Term Debt
49415000
Annuals > 0 > balance Sheet > total Liabilities
106819000
Annuals > 0 > balance Sheet > equity
-16367000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-18438000
Annuals > 0 > cash Flow > depreciation
1990000
Annuals > 0 > cash Flow > change In Working Capital
24534000
Annuals > 0 > cash Flow > cash From Operations
19465000
Annuals > 0 > cash Flow > capital Expenditures
1660000
Annuals > 0 > cash Flow > cash From Investing
-13210000
Annuals > 0 > cash Flow > cash From Financing
33324000
Annuals > 0 > cash Flow > net Change In Cash
39580000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-0.6335859303924862
Annuals > 0 > ratios > PB
-12.403540685525753
Annuals > 0 > ratios > ROE
112.65351011181035
Annuals > 0 > ratios > ROA
-20.38429222128864
Annuals > 0 > ratios > FCF
17805000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
0.6971144434438745
Annuals > 0 > health Score
50
Annuals > 1 > quarter
2024-03-31
Annuals > 1 > income Statement > revenue
9160000
Annuals > 1 > income Statement > cost Of Revenue
-128000
Annuals > 1 > income Statement > gross Profit
9160000
Annuals > 1 > income Statement > operating Expenses
30137000
Annuals > 1 > income Statement > operating Income
-20977000
Annuals > 1 > income Statement > interest Expense
4617000
Annuals > 1 > income Statement > pretax Income
-24950000
Annuals > 1 > income Statement > net Income
-25038000
Annuals > 1 > income Statement > eps
-0.88101473417796
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
28419502
Annuals > 1 > income Statement > income Tax Expense
88000
Annuals > 1 > income Statement > EBITDA
-18614000
Annuals > 1 > income Statement > operating Margin
-229.00655021834064
Annuals > 1 > income Statement > total Other Income Expense Net
-3973000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
19460000
Annuals > 1 > balance Sheet > short Term Investments
-729000
Annuals > 1 > balance Sheet > receivables
2273000
Annuals > 1 > balance Sheet > inventories
-19000
Annuals > 1 > balance Sheet > total Current Assets
27258000
Annuals > 1 > balance Sheet > property Plant Equipment
5433000
Annuals > 1 > balance Sheet > total Assets
36948000
Annuals > 1 > balance Sheet > payables
1849000
Annuals > 1 > balance Sheet > short Term Debt
6161000
Annuals > 1 > balance Sheet > long Term Debt
50541000
Annuals > 1 > balance Sheet > total Liabilities
77772000
Annuals > 1 > balance Sheet > equity
-40824000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-25038000
Annuals > 1 > cash Flow > depreciation
1719000
Annuals > 1 > cash Flow > change In Working Capital
3178000
Annuals > 1 > cash Flow > cash From Operations
-11922000
Annuals > 1 > cash Flow > capital Expenditures
1191000
Annuals > 1 > cash Flow > cash From Investing
-613000
Annuals > 1 > cash Flow > cash From Financing
25528000
Annuals > 1 > cash Flow > net Change In Cash
12993000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-0.88101473417796
Annuals > 1 > ratios > PB
-4.856320937487752
Annuals > 1 > ratios > ROE
61.33156966490299
Annuals > 1 > ratios > ROA
-67.76550828190972
Annuals > 1 > ratios > FCF
-13113000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-1.4315502183406112
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2023-03-31
Annuals > 2 > income Statement > revenue
9944000
Annuals > 2 > income Statement > cost Of Revenue
0
Annuals > 2 > income Statement > gross Profit
9944000
Annuals > 2 > income Statement > operating Expenses
33989000
Annuals > 2 > income Statement > operating Income
-24025000
Annuals > 2 > income Statement > interest Expense
3932000
Annuals > 2 > income Statement > pretax Income
-32010000
Annuals > 2 > income Statement > net Income
-32010000
Annuals > 2 > income Statement > eps
-1.2708180824907431
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
25188499
Annuals > 2 > income Statement > income Tax Expense
-4016000
Annuals > 2 > income Statement > EBITDA
-26413000
Annuals > 2 > income Statement > operating Margin
-241.60297666934832
Annuals > 2 > income Statement > total Other Income Expense Net
-7964000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
6467000
Annuals > 2 > balance Sheet > short Term Investments
3000
Annuals > 2 > balance Sheet > receivables
2103000
Annuals > 2 > balance Sheet > inventories
760000
Annuals > 2 > balance Sheet > total Current Assets
19568000
Annuals > 2 > balance Sheet > property Plant Equipment
6373000
Annuals > 2 > balance Sheet > total Assets
29339000
Annuals > 2 > balance Sheet > payables
3591000
Annuals > 2 > balance Sheet > short Term Debt
43455000
Annuals > 2 > balance Sheet > long Term Debt
11708000
Annuals > 2 > balance Sheet > total Liabilities
71633000
Annuals > 2 > balance Sheet > equity
-42294000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-32010000
Annuals > 2 > cash Flow > depreciation
1665000
Annuals > 2 > cash Flow > change In Working Capital
-3036000
Annuals > 2 > cash Flow > cash From Operations
-21005000
Annuals > 2 > cash Flow > capital Expenditures
1027000
Annuals > 2 > cash Flow > cash From Investing
1298000
Annuals > 2 > cash Flow > cash From Financing
1556000
Annuals > 2 > cash Flow > net Change In Cash
-18150000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-1.2708180824907431
Annuals > 2 > ratios > PB
-4.154607486262827
Annuals > 2 > ratios > ROE
75.68449425450419
Annuals > 2 > ratios > ROA
-109.10392310576367
Annuals > 2 > ratios > FCF
-22032000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-2.2156074014481093
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2022-03-31
Annuals > 3 > income Statement > revenue
4090000
Annuals > 3 > income Statement > cost Of Revenue
0
Annuals > 3 > income Statement > gross Profit
4090000
Annuals > 3 > income Statement > operating Expenses
27904000
Annuals > 3 > income Statement > operating Income
-23814000
Annuals > 3 > income Statement > interest Expense
1844000
Annuals > 3 > income Statement > pretax Income
-24806000
Annuals > 3 > income Statement > net Income
-24806000
Annuals > 3 > income Statement > eps
-0.997611018007631
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
24865403
Annuals > 3 > income Statement > income Tax Expense
874000
Annuals > 3 > income Statement > EBITDA
-21446000
Annuals > 3 > income Statement > operating Margin
-582.2493887530562
Annuals > 3 > income Statement > total Other Income Expense Net
-994000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
24617000
Annuals > 3 > balance Sheet > short Term Investments
1968000
Annuals > 3 > balance Sheet > receivables
819000
Annuals > 3 > balance Sheet > inventories
1763000
Annuals > 3 > balance Sheet > total Current Assets
34074000
Annuals > 3 > balance Sheet > property Plant Equipment
7030000
Annuals > 3 > balance Sheet > total Assets
44303000
Annuals > 3 > balance Sheet > payables
2982000
Annuals > 3 > balance Sheet > short Term Debt
28345000
Annuals > 3 > balance Sheet > long Term Debt
16249000
Annuals > 3 > balance Sheet > total Liabilities
57674000
Annuals > 3 > balance Sheet > equity
-13371000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-24806000
Annuals > 3 > cash Flow > depreciation
1516000
Annuals > 3 > cash Flow > change In Working Capital
-2367000
Annuals > 3 > cash Flow > cash From Operations
-21362000
Annuals > 3 > cash Flow > capital Expenditures
1974000
Annuals > 3 > cash Flow > cash From Investing
-316000
Annuals > 3 > cash Flow > cash From Financing
-800000
Annuals > 3 > cash Flow > net Change In Cash
-22478000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.997611018007631
Annuals > 3 > ratios > PB
-12.972930321441925
Annuals > 3 > ratios > ROE
185.52090344776008
Annuals > 3 > ratios > ROA
-55.99169356476988
Annuals > 3 > ratios > FCF
-23336000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-5.705623471882641
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.5702647244154607
Valuation > metrics > PB
-6.420762838055024
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
52.487593898802764
Profitability > metrics > ROA
-26.204445971409264
Profitability > metrics > Net Margin
-1.3850792850692346
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-3.2192121180863325
Risk > final Score
17
Risk > verdict
High
Liquidity > metrics > Current Ratio
6.608789838571219
Liquidity > metrics > Quick Ratio
6.608789838571219
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
25
Prev Risks > 1
13
Prev Risks > 2
19
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:11:24.424Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-06-16
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-12-09
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2021-06-30
Earnings History > 2 > report Date
2021-09-30
Earnings History > 2 > date
2021-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
EUR
Earnings History > 2 > eps Actual
-0.2722
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.2722
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2021-03-31
Earnings History > 3 > report Date
2021-06-30
Earnings History > 3 > date
2021-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
EUR
Earnings History > 3 > eps Actual
-0.2787
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.2787
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2020-12-31
Earnings History > 4 > report Date
2021-03-31
Earnings History > 4 > date
2020-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
EUR
Earnings History > 4 > eps Actual
-0.2124
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.2124
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2020-09-30
Earnings History > 5 > report Date
2020-12-31
Earnings History > 5 > date
2020-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
-0.2213
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.2213
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2020-06-30
Earnings History > 6 > report Date
2020-09-30
Earnings History > 6 > date
2020-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
-0.299
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.299
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2020-03-31
Earnings History > 7 > report Date
2020-06-30
Earnings History > 7 > date
2020-03-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
-0.2865
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.2865
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-12-31
Earnings History > 8 > report Date
2020-03-31
Earnings History > 8 > date
2019-12-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
-0.4084
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.4084
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-09-30
Earnings History > 9 > report Date
2019-12-31
Earnings History > 9 > date
2019-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
-0.4157
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.4157
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2019-06-30
Earnings History > 10 > report Date
2019-09-30
Earnings History > 10 > date
2019-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
-0.2453
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.2453
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2019-03-31
Earnings History > 11 > report Date
2019-06-30
Earnings History > 11 > date
2019-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
-0.2559
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.2559
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-12-31
Earnings History > 12 > report Date
2019-03-31
Earnings History > 12 > date
2018-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
-0.2757
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.2757
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-09-30
Earnings History > 13 > report Date
2018-12-31
Earnings History > 13 > date
2018-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
-0.2816
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.2816
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2018-06-30
Earnings History > 14 > report Date
2018-09-30
Earnings History > 14 > date
2018-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
-0.3947
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.3947
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2018-03-31
Earnings History > 15 > report Date
2018-06-30
Earnings History > 15 > date
2018-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
-0.397
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.397
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2017-12-31
Earnings History > 16 > report Date
2018-03-31
Earnings History > 16 > date
2017-12-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
-0.2007
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.2007
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2017-09-30
Earnings History > 17 > report Date
2017-12-31
Earnings History > 17 > date
2017-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
EUR
Earnings History > 17 > eps Actual
-0.1955
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.1955
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2017-06-30
Earnings History > 18 > report Date
2017-09-30
Earnings History > 18 > date
2017-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
EUR
Earnings History > 18 > eps Actual
-0.2009
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.2009
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2017-03-31
Earnings History > 19 > report Date
2017-06-30
Earnings History > 19 > date
2017-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
EUR
Earnings History > 19 > eps Actual
-0.1942
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.1942
Earnings History > 19 > surprise Percent
-
MedinCell S.A., a clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France. The company develops solutions based on BEPO, a long-acting injectable technology. It offers UZEDY (mdc-IRM) for the treatment of schizophrenia in adults and bipolar I disorder. It is also developing mdc-TJK, a subcutaneous injection that is in the NDA preparation stage for the treatment of schizophrenia in adults; and mdc-CWM, a sustained-release formulation of celecoxib in Phase III trials for use in the treatment of reduction of postoperative pain and inflammation in total knee arthroplasty surgery. In addition, its product candidates in preclinical trials include mdc-WWM for contraception; and mdc-STM for malaria. It has strategic collaborations with AbbVie to develop, manufacture, and commercialize six long-acting injectable therapeutic products; and IM4TB to develop a long-acting injectable version of Macozinone for the treatment of tuberculosis. MedinCell S.A. was incorporated in 2003 and is based in Jacou, France.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ATeva Pharmaceuticals: Why It's Time To Cash Out (Rating Downgrade) Seeking Alpha
Read more →(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of MedinCell S.A
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
—
Date
2025-09-30
EPS Actual
—
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.